Statistics Report: Global Psoriatic Arthritis Therapeutics Market Size & Share to Surpass USD 16.71 Bn by 2025

Global Psoriatic Arthritis Therapeutics Market

Global Psoriatic Arthritis Therapeutics Market

Global Psoriatic Arthritis Therapeutics Market

Global Psoriatic Arthritis Therapeutics Market

Global Psoriatic Arthritis Therapeutics Market

Global Psoriatic Arthritis Therapeutics Market

Global Psoriatic Arthritis Therapeutics Market Is Expected To Reach Around USD 16.71 Billion By 2025. at a CAGR of around 11.2% between 2019 and 2025.

Statistics Report: Global Psoriatic Arthritis Therapeutics Market Size & Share to Surpass USD 16.71 Bn by 2025, Predicts Zion Market Research | Industry Trends, Growth, Value & Forecast by ZMR”
— Zion Market Research
SUITE N202, NEW YORK, UNITED STATES, September 15, 2022 /EINPresswire.com/ -- Zion Market Research has published a new report titled โ€œglobal Psoriatic Arthritis Therapeutics Market by Drug Class (Interleukin Inhibitors, TNF Inhibitors, PDE4 Inhibitors, and Others), by Disease Type (Asymmetric Psoriatic Arthritis, Symmetric Psoriatic Arthritis, Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis, Spondylitis, and Arthritis Mutilans), and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018โ€“2025โ€.

๐€๐œ๐œ๐จ๐ซ๐๐ข๐ง๐  ๐ญ๐จ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฉ๐ฌ๐จ๐ซ๐ข๐š๐ญ๐ข๐œ ๐š๐ซ๐ญ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐š๐ฉ๐ฉ๐ซ๐จ๐ฑ๐ข๐ฆ๐š๐ญ๐ž๐ฅ๐ฒ ๐”๐’๐ƒ ๐Ÿ– ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ– ๐š๐ง๐ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ ๐ž๐ง๐ž๐ซ๐š๐ญ๐ž ๐š๐ซ๐จ๐ฎ๐ง๐ ๐”๐’๐ƒ ๐Ÿ๐Ÿ”.๐Ÿ•๐Ÿ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“, ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐š๐ซ๐จ๐ฎ๐ง๐ ๐Ÿ๐Ÿ.๐Ÿ% ๐›๐ž๐ญ๐ฐ๐ž๐ž๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— ๐š๐ง๐ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“.

Psoriatic arthritis is a condition prevalent in psoriasis patients and involves inflammatory arthropathy. This leads to swelling, stiffness, and tenderness of joints caused by the degeneration of cartilage bones in the joints. Sometimes, lesions may appear later than joints problems. This is a non-curable condition, but controlling the symptoms can prevent joint damage.

Psoriatic arthritis is caused by abnormal immune responses, which leads to joint inflammation and overproduction of skin cells. Psoriatic arthritis can affect any body part and cause swollen and painful joints that feel warm when touched. The global psoriatic arthritis therapeutics market is mainly driven by the increased prevalence of psoriasis that is leading to the rise in the number of psoriatic arthritis patients.

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐Ÿ“๐Ÿ’ ๐“๐š๐›๐ฅ๐ž๐ฌ & ๐Ÿ‘๐ŸŽ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐ฌ๐ฉ๐ซ๐ž๐š๐ ๐จ๐ฏ๐ž๐ซ ๐Ÿ๐Ÿ๐ŸŽ ๐๐š๐ ๐ž๐ฌ ๐š๐ง๐ ๐ข๐ง-๐๐ž๐ฉ๐ญ๐ก ๐“๐Ž๐‚ ๐จ๐ง โ€œ๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐ฌ๐จ๐ซ๐ข๐š๐ญ๐ข๐œ ๐€๐ซ๐ญ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐๐ฒ ๐“๐ฒ๐ฉ๐ž, ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐’๐ข๐ณ๐ž, ๐’๐ก๐š๐ซ๐ž, ๐“๐ซ๐ž๐ง๐๐ฌ, ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ, ๐š๐ง๐ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿโ€“๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–โ€.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐จ๐Ÿ ๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐ฌ๐จ๐ซ๐ข๐š๐ญ๐ข๐œ ๐€๐ซ๐ญ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ @ https://www.zionmarketresearch.com/sample/psoriatic-arthritis-therapeutics-market

๐Ž๐ฎ๐ซ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ˆ๐ง๐œ๐ฅ๐ฎ๐๐ž๐ฌ:

-2022 Updated Report Introduction, Overview, and In-depth industry analysis
-COVID-19 Pandemic Outbreak Impact Analysis Included
-218 + Pages Research Report (Inclusion of Updated Research)
-Provide Chapter-wise guidance on Request
-2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
-Includes an Updated List of tables & figures
-Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
-Zion Market Research Methodology

As per the National Psoriasis Foundation report, in 2018, around 10 to 30% percent of people with psoriasis developed psoriatic arthritis. Furthermore, increasing use of biologics, growing R&D activities of pipeline drugs, and rising disease awareness among people coupled with a large population with unmet needs is also expected to propel the global psoriatic arthritis therapeutics market.

However, stringent regulatory approval process, high cost of drugs, and lack of proper diagnosis of psoriatic arthritis may hamper the psoriatic arthritis therapeutics market globally over the projected time period.

North America is expected to dominate the psoriatic arthritis therapeutics market globally over the forecast time period, owing to the increasing adoption of biological drugs for arthritis treatment and the rising prevalence of psoriatic arthritis. The region is also among the largest consumers of psoriatic arthritis therapeutics.

Additionally, the constantly rising number of new product approvals supported by increasing healthcare expenditure and advanced healthcare infrastructure is also driving this regional market. Furthermore, the presence of developed countries, such as the U.S. and Canada, is expected to further promote the regionโ€™s psoriatic arthritis therapeutics market.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐…๐ซ๐ž๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ƒ๐… ๐๐ซ๐จ๐œ๐ก๐ฎ๐ซ๐ž: https://www.zionmarketresearch.com/requestbrochure/psoriatic-arthritis-therapeutics-market

Europe is expected to hold the second spot in the psoriatic arthritis therapeutics market globally in the years ahead, due to the presence of advanced healthcare infrastructure, a growing number of R&D activities conducted by the leading market players, and ongoing technological advancements made in the healthcare industry.

The Asia Pacific psoriatic arthritis therapeutics market is expected to grow notably in the future, due to the presence of developing economies of India and China and increasing healthcare facilities across the region. These countries have a large consumer base, which is also fuelling this regional market. Increasing disease awareness among the regional population, development of advanced healthcare infrastructure, and growing investments made by major market players is positively influencing the regional market.

Latin America and the Middle East and Africa are expected to grow moderately over the estimated time period, owing to the developing healthcare infrastructure and constant improvements made in the existing healthcare facilities.

๐“๐จ๐ฉ๐จ๐ ๐ซ๐š๐ฉ๐ก๐ข๐œ๐š๐ฅ ๐’๐ญ๐ฎ๐๐ฒ:

1. North America (the United States, Canada and Mexico)

2. Asia-Pacific (Japan, China, India, Australia etc)

3. Europe (Germany, UK, France etc)

4. Central and South America (Brazil, Argentina etc)

5. The Middle East and Africa (United Arab Emirates, Saudi Arabia, South Africa etc)

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ญ https://www.zionmarketresearch.com/report/psoriatic-arthritis-therapeutics-market

๐’๐จ๐ฆ๐ž ๐ฆ๐š๐ฃ๐จ๐ซ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฉ๐ฌ๐จ๐ซ๐ข๐š๐ญ๐ข๐œ ๐š๐ซ๐ญ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ž

-Bristol-Myers Squibb
-Amgen
-Celgene Corporation
-Janssen Biotech
-UCB
-Pfizer
-Biogen
-Novartis AG
-Eli Lilly and Company
-AbbVie.

This report segments the global psoriatic arthritis therapeutics market into:

๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐ฌ๐จ๐ซ๐ข๐š๐ญ๐ข๐œ ๐€๐ซ๐ญ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐ƒ๐ซ๐ฎ๐  ๐‚๐ฅ๐š๐ฌ๐ฌ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

-Interleukin Inhibitors
-TNF Inhibitors
-PDE4 Inhibitors
-Others

๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐ฆ๐จ๐ซ๐ž ๐š๐›๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐ž๐Ÿ๐จ๐ซ๐ž ๐ฉ๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž @ https://www.zionmarketresearch.com/inquiry/psoriatic-arthritis-therapeutics-market

๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐ฌ๐จ๐ซ๐ข๐š๐ญ๐ข๐œ ๐€๐ซ๐ญ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ฒ๐ฉ๐ž ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

-Asymmetric Psoriatic Arthritis
-Symmetric Psoriatic Arthritis
-Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis
-Spondylitis
-Arthritis Mutilans

๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐ฌ๐จ๐ซ๐ข๐š๐ญ๐ข๐œ ๐€๐ซ๐ญ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

-Hospital Pharmacies
-Online Pharmacies
-Retail Pharmacies

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ž๐ ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ https://www.zionmarketresearch.com/custom/4271

๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ ๐จ๐Ÿ ๐‚๐Ž๐•๐ˆ๐ƒ-๐Ÿ๐Ÿ— โ€“

The long-term consequences of COVID-19 are expected to have a negative influence on industry growth over the predicted period, making it an unprecedented worldwide public health emergency. As we continue to dig further into the challenges surrounding COVID-19, we are better able to identify possible solutions. Consumer demand, purchasing habits, supply chain rerouting, current market factors, and substantial government initiatives are all examined in the report on COVID-19. In light of the impact of COVID-19 on the market, the updated study offers new insights, analyses, estimates, and projections.

๐…๐‘๐„๐๐”๐„๐๐“๐‹๐˜ ๐€๐’๐Š๐„๐ƒ ๐๐”๐„๐’๐“๐ˆ๐Ž๐๐’

1)Which key factors will influence Psoriatic Arthritis Therapeutics Market growth over 2022-2028?
2)What will be the value of the Psoriatic Arthritis Therapeutics Market during 2022-2028?
3)Which region will contribute notably towards the Psoriatic Arthritis Therapeutics value?

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐™๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

๐๐ฌ๐จ๐ซ๐ข๐š๐ญ๐ข๐œ ๐€๐ซ๐ญ๐ก๐ซ๐ข๐ญ๐ข๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐’๐ข๐ณ๐ž

Critical Limb Ischemia Treatment Market -

Pharmacovigilance Market - https://www.zionmarketresearch.com/report/pharmacovigilance-market

Nanoemulsion Market - https://www.zionmarketresearch.com/report/nanoemulsion-market

Intravenous Immunoglobulin Market - https://www.zionmarketresearch.com/report/intravenous-immunoglobulin-ivig-market

Peptide and Anticoagulant Drugs Market - https://www.zionmarketresearch.com/report/peptide-anticoagulant-drugs-market

Kavita More
Zion Market Research
+1 855-465-4651
Kavita.m@marketresearchstore.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Other